BCTX logo

BriaCell Therapeutics (BCTX) EBITDA

Annual EBITDA

-$33.25 M
-$9.99 M-42.95%

July 31, 2024

Summary

Performance

1-Year Change

-42.95%

3-Year Change

-142.28%

5-Year Change

-611.61%

15-Year Change

-1186.67%

BCTX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.95%
BCTX annual EBITDA is higher than 40.95% of companies in Healthcare sector

High & Low

All-time High

-$8600.00

3-Year Low

-$33.25 M
BCTX annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jul 31, 2024
BCTX previous annual earnings announcement was published on Jul 31, 2024

Next Annual Earnings Report Date

N/A
BCTX next annual earnings announcement has not yet been scheduled

OtherBCTXprofitabilitymetrics:

Annual Revenue

-
BCTX annual revenue value is unknown

Annual Net Income

-$4.79 M
BCTX annual net profit is -$4.79 million

Annual EBIT

-$33.33 M
BCTX annual earnings before interest & taxes is -$33.33 million

Annual EPS

-$4.35
BCTX annual earnings per share is -$4.35

Quarterly EBITDA

-$5.13 M
+$569.30 K+10.00%

October 31, 2024

Summary

Performance

3-Month Change

+10%

1-Year Change

+44.44%

3-Year Change

-145.92%

5-Year Change

-145.92%

BCTX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.29%
BCTX quarterly EBITDA is higher than 47.29% of companies in Healthcare sector

High & Low

All-time High

$11.16 M
BCTX quarterly EBITDA is currently -145.92% below its historical high of $11.16 million

3-Year Low

-$10.01 M

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
BCTX previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
BCTX next earnings announcement is scheduled for Mar 18, 2025

OtherBCTXprofitabilitymetrics:

Quarterly Revenue

-
BCTX quarterly revenue value is unknown

Quarterly Net Income

-$5.80 M
BCTX quarterly net profit is -$5.80 million

Quarterly EBIT

-$5.15 M
BCTX quarterly earnings before interest & taxes is -$5.15 million

Quarterly EPS

-$3.30
BCTX quarterly earnings per share is -$3.30

TTM EBITDA

-$29.87 M
+$3.37 M+10.15%

October 31, 2024

Summary

Performance

3-Month Change

+10.15%

1-Year Change

+15.26%

3-Year Change

-1.27%

5-Year Change

-1.27%

BCTX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.44%
BCTX TTM EBITDA is higher than 41.44% of companies in Healthcare sector

High & Low

All-time High

$1.49 M
BCTX TTM EBITDA is currently -2102.76% below its historical high of $1.49 million

3-Year Low

-$42.53 M

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
BCTX previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
BCTX next earnings announcement is scheduled for Mar 18, 2025

OtherBCTXprofitabilitymetrics:

TTM Revenue

-
BCTX TTM revenue value is unknown

TTM Net Income

-$16.60 M
BCTX TTM net profit is -$16.60 million

TTM EBIT

-$29.98 M
BCTX TTM earnings before interest & taxes is -$29.98 million

TTM EPS

-$13.35
BCTX TTM earnings per share is -$13.35

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$33.25 M
BCTX annual EBITDA is -$33.25 million

Annual Net Income

-$4.79 M
BCTX annual net profit is -$4.79 million

Annual Interest Expense

-
BCTX annual interest expense value is unknown

Annual Income Tax

-
BCTX annual income tax value is unknown

Annual D&A

$83.90 K
BCTX annual depreciation & amortization is $83.90 thousand

BCTX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-43.0%+44.4%+15.3%
3 y3 years-142.3%-145.9%-1.3%
5 y5 years-611.6%-145.9%-1.3%

BCTX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-142.3%at low-145.9%+48.8%-536.5%+29.8%
5 y5-year-735.4%at low-145.9%+81.4%-2102.8%+29.8%
alltimeall time<-9999.0%at low-145.9%+81.4%-2102.8%+29.8%

BriaCell Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Oct 2024
-
-$5.13 M(-10.0%)
-$29.87 M(-10.1%)
Jul 2024
-$33.25 M(+43.0%)
-$5.70 M(-38.3%)
-$33.25 M(-5.7%)
Apr 2024
-
-$9.23 M(-6.1%)
-$35.25 M(+11.2%)
Jan 2024
-
-$9.83 M(+15.6%)
-$31.70 M(+20.3%)
Oct 2023
-
-$8.50 M(+10.4%)
-$26.36 M(+13.3%)
Jul 2023
-$23.26 M(-13.3%)
-$7.70 M(+35.8%)
-$23.26 M(+45.3%)
Apr 2023
-
-$5.67 M(+26.6%)
-$16.00 M(-21.3%)
Jan 2023
-
-$4.48 M(-17.0%)
-$20.34 M(+333.4%)
Oct 2022
-
-$5.40 M(+1109.2%)
-$4.69 M(-82.5%)
Jul 2022
-$26.82 M(+95.5%)
-$446.50 K(-95.5%)
-$26.82 M(-36.9%)
Apr 2022
-
-$10.01 M(-189.7%)
-$42.53 M(+44.2%)
Jan 2022
-
$11.16 M(-140.6%)
-$29.50 M(-27.8%)
Oct 2021
-
-$27.53 M(+70.5%)
-$40.85 M(+197.7%)
Jul 2021
-$13.72 M(+244.8%)
-$16.15 M(-635.5%)
-$13.72 M(-1020.0%)
Apr 2021
-
$3.02 M(-1718.8%)
$1.49 M(-173.8%)
Jan 2021
-
-$186.30 K(-53.6%)
-$2.02 M(-37.9%)
Oct 2020
-
-$401.80 K(-57.1%)
-$3.25 M(-20.6%)
Jul 2020
-$3.98 M(-14.8%)
-$936.20 K(+88.0%)
-$4.10 M(-15.0%)
Apr 2020
-
-$498.00 K(-64.9%)
-$4.82 M(-11.5%)
Jan 2020
-
-$1.42 M(+13.9%)
-$5.45 M(+4.3%)
Oct 2019
-
-$1.25 M(-24.9%)
-$5.22 M(+10.0%)
Jul 2019
-$4.67 M(+13.2%)
-$1.66 M(+47.4%)
-$4.75 M(-2.1%)
Apr 2019
-
-$1.13 M(-5.7%)
-$4.85 M(+0.3%)
Jan 2019
-
-$1.19 M(+54.7%)
-$4.84 M(+9.2%)
Oct 2018
-
-$771.80 K(-56.1%)
-$4.43 M(+6.5%)
Jul 2018
-$4.13 M(+59.7%)
-$1.76 M(+58.3%)
-$4.16 M(+19.5%)
Apr 2018
-
-$1.11 M(+41.2%)
-$3.48 M(+7.8%)
Jan 2018
-
-$787.30 K(+57.6%)
-$3.23 M(+16.2%)
Oct 2017
-
-$499.60 K(-53.8%)
-$2.78 M(+6.7%)
Jul 2017
-$2.58 M(+55.2%)
-$1.08 M(+25.7%)
-$2.60 M(+50.7%)
Apr 2017
-
-$859.30 K(+154.3%)
-$1.73 M(+51.5%)
Jan 2017
-
-$337.90 K(+4.0%)
-$1.14 M(-27.7%)
Oct 2016
-
-$324.80 K(+58.3%)
-$1.58 M(+0.8%)
Jul 2016
-$1.67 M(-38.9%)
-$205.20 K(-24.7%)
-$1.56 M(+5.0%)
Apr 2016
-
-$272.50 K(-64.8%)
-$1.49 M(-7.1%)
Jan 2016
-
-$775.10 K(+148.3%)
-$1.60 M(-44.1%)
Oct 2015
-
-$312.20 K(+138.3%)
-$2.87 M(+9.9%)
DateAnnualQuarterlyTTM
Jul 2015
-$2.73 M(+525.2%)
-$131.00 K(-66.1%)
-$2.61 M(-1.6%)
Apr 2015
-
-$386.00 K(-81.1%)
-$2.65 M(+12.1%)
Jan 2015
-
-$2.04 M(+3607.5%)
-$2.37 M(+474.4%)
Oct 2014
-
-$55.00 K(-68.5%)
-$412.30 K(-5.9%)
Jul 2014
-$436.20 K(+2.9%)
-$174.50 K(+74.8%)
-$438.10 K(+23.1%)
Apr 2014
-
-$99.80 K(+20.2%)
-$355.80 K(-5.1%)
Jan 2014
-
-$83.00 K(+2.7%)
-$374.80 K(-6.4%)
Oct 2013
-
-$80.80 K(-12.4%)
-$400.60 K(-6.0%)
Jul 2013
-$423.90 K(-22.9%)
-$92.20 K(-22.4%)
-$426.10 K(-8.0%)
Apr 2013
-
-$118.80 K(+9.2%)
-$463.00 K(-1.4%)
Jan 2013
-
-$108.80 K(+2.4%)
-$469.50 K(-6.5%)
Oct 2012
-
-$106.30 K(-17.7%)
-$502.00 K(-7.9%)
Jul 2012
-$550.10 K(-47.6%)
-$129.10 K(+3.0%)
-$545.10 K(-40.8%)
Apr 2012
-
-$125.30 K(-11.3%)
-$921.00 K(-10.6%)
Jan 2012
-
-$141.30 K(-5.4%)
-$1.03 M(-4.0%)
Oct 2011
-
-$149.40 K(-70.4%)
-$1.07 M(+4.1%)
Jul 2011
-$1.05 M(+225.0%)
-$505.00 K(+115.3%)
-$1.03 M(+82.0%)
Apr 2011
-
-$234.60 K(+27.3%)
-$566.50 K(+13.6%)
Jan 2011
-
-$184.30 K(+71.9%)
-$498.50 K(+36.2%)
Oct 2010
-
-$107.20 K(+165.3%)
-$366.00 K(+15.9%)
Jul 2010
-$323.30 K(+38.3%)
-$40.40 K(-75.8%)
-$315.70 K(-24.0%)
Apr 2010
-
-$166.60 K(+221.6%)
-$415.60 K(+61.1%)
Jan 2010
-
-$51.80 K(-9.0%)
-$257.90 K(+7.4%)
Oct 2009
-
-$56.90 K(-59.4%)
-$240.20 K(+2.0%)
Jul 2009
-$233.70 K(+104.8%)
-$140.30 K(+1476.4%)
-$235.50 K(+55.0%)
Apr 2009
-
-$8900.00(-73.9%)
-$151.90 K(-11.3%)
Jan 2009
-
-$34.10 K(-34.7%)
-$171.30 K(+9.3%)
Oct 2008
-
-$52.20 K(-7.9%)
-$156.70 K(+36.5%)
Jul 2008
-$114.10 K(-11.6%)
-$56.70 K(+100.4%)
-$114.80 K(+17.7%)
Apr 2008
-
-$28.30 K(+45.1%)
-$97.50 K(+18.6%)
Jan 2008
-
-$19.50 K(+89.3%)
-$82.20 K(-23.6%)
Oct 2007
-
-$10.30 K(-73.9%)
-$107.60 K(-14.5%)
Jul 2007
-$129.10 K(+1401.2%)
-$39.40 K(+203.1%)
-$125.80 K(+45.6%)
Apr 2007
-
-$13.00 K(-71.0%)
-$86.40 K(+17.7%)
Jan 2007
-
-$44.90 K(+57.5%)
-$73.40 K(+157.5%)
Oct 2006
-
-$28.50 K
-$28.50 K
Jul 2006
-$8600.00
-
-

FAQ

  • What is BriaCell Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for BriaCell Therapeutics?
  • What is BriaCell Therapeutics annual EBITDA year-on-year change?
  • What is BriaCell Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for BriaCell Therapeutics?
  • What is BriaCell Therapeutics quarterly EBITDA year-on-year change?
  • What is BriaCell Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for BriaCell Therapeutics?
  • What is BriaCell Therapeutics TTM EBITDA year-on-year change?

What is BriaCell Therapeutics annual EBITDA?

The current annual EBITDA of BCTX is -$33.25 M

What is the all time high annual EBITDA for BriaCell Therapeutics?

BriaCell Therapeutics all-time high annual EBITDA is -$8600.00

What is BriaCell Therapeutics annual EBITDA year-on-year change?

Over the past year, BCTX annual EBITDA has changed by -$9.99 M (-42.95%)

What is BriaCell Therapeutics quarterly EBITDA?

The current quarterly EBITDA of BCTX is -$5.13 M

What is the all time high quarterly EBITDA for BriaCell Therapeutics?

BriaCell Therapeutics all-time high quarterly EBITDA is $11.16 M

What is BriaCell Therapeutics quarterly EBITDA year-on-year change?

Over the past year, BCTX quarterly EBITDA has changed by +$4.10 M (+44.44%)

What is BriaCell Therapeutics TTM EBITDA?

The current TTM EBITDA of BCTX is -$29.87 M

What is the all time high TTM EBITDA for BriaCell Therapeutics?

BriaCell Therapeutics all-time high TTM EBITDA is $1.49 M

What is BriaCell Therapeutics TTM EBITDA year-on-year change?

Over the past year, BCTX TTM EBITDA has changed by +$5.38 M (+15.26%)